High Point Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84K Hold
70
0.07% 115
2026
Q1
$64.4K Buy
70
+15
+27% +$15.2K 0.06% 121
2025
Q4
$59.1K Buy
+55
New +$52.6K 0.06% 130

Other funds holding LLY

High Point Wealth Management's LLY Position: Q2 2026 in Review

High Point Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 70 shares worth $84K. The position accounts for 0.07% of the portfolio, ranked #115.

High Point Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • High Point Wealth Management held 70 shares of Eli Lilly worth $84K as of Q2 2026.
  • High Point Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.07% of High Point Wealth Management's portfolio in Q2 2026, its #115 holding.
  • High Point Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on High Point Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.